Profile
Sector:
HealthcareCountry:
United StatesIPO:
09 May 2007Website:
http://www.therapeuticsmd.comNext earnings report:
05 March 2025Last dividends:
N/ANext dividends:
N/APrice
regular market | 35 min agoDividend
Analysts recommendations
Institutional Ownership
TXMD Latest News
The Dow Jones index closed higher by more than 450 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.
TherapeuticsMD (TXMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
What type of business is TherapeuticsMD?
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
What sector is TherapeuticsMD in?
TherapeuticsMD is in the Healthcare sector
What industry is TherapeuticsMD in?
TherapeuticsMD is in the Drug Manufacturers - Specialty & Generic industry
What country is TherapeuticsMD from?
TherapeuticsMD is headquartered in United States
When did TherapeuticsMD go public?
TherapeuticsMD initial public offering (IPO) was on 09 May 2007
What is TherapeuticsMD website?
https://www.therapeuticsmd.com
Is TherapeuticsMD in the S&P 500?
No, TherapeuticsMD is not included in the S&P 500 index
Is TherapeuticsMD in the NASDAQ 100?
No, TherapeuticsMD is not included in the NASDAQ 100 index
Is TherapeuticsMD in the Dow Jones?
No, TherapeuticsMD is not included in the Dow Jones index
When was TherapeuticsMD the previous earnings report?
No data
When does TherapeuticsMD earnings report?
The next expected earnings date for TherapeuticsMD is 05 March 2025